Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07534280Completed
Randomised, open-label trial in acute rhinosinusitis (ARS) (3 arms), sponsored by Deraya University. Primary endpoint: Sino-Nasal Outcome Test 16 at 14 days. Started Nov 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07534280.